Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4
- PMID: 10941837
- DOI: 10.1007/s002510000183
Genomic organization of the human leukocyte immunoglobulin-like receptors within the leukocyte receptor complex on chromosome 19q13.4
Abstract
The leukocyte immunoglobulin (Ig)-like receptors (LIRs) comprise a family of cell surface receptors that couple to either activating or inhibitory signals depending on the nature of their transmembrane and cytoplasmic domains. We describe the organization and fine localization of the genes for LIR-1 and LIR-5, which are inhibitory receptors, and LIR-6, which is an activating receptor. The genomic organization of all three genes is highly conserved from the signal peptide through the membrane-proximal Ig domain but diverges thereafter depending on the inhibitory or activating nature of the gene product. The 3' untranslated region of the gene for LIR-6 contains a 37-base pair repeat not present in the LIR-1 or LIR-5 genes. 5' rapid amplification of cDNA ends defined the putative transcription initiation site of the LIR-5 gene, which is TATA-less. A nucleotide substitution in the LIR-5 gene led to loss of an intron present in the 5' untranslated region of the LIR-1 and LIR-6 genes. Differences in the genomic structure of these three LIR genes suggests possible mechanisms for their differential expression in cells of hematopoietic lineage. The three genes are in a region of Chromosome 19q13.4 that is immediately centromeric of the killer cell Ig-like receptor genes and are separated from one another by approximately 20 to 30 kb, suggesting that they arose by gene duplication from a common ancestor.
Similar articles
-
Conserved organization of the ILT/LIR gene family within the polymorphic human leukocyte receptor complex.Immunogenetics. 2001 May-Jun;53(4):270-8. doi: 10.1007/s002510100332. Immunogenetics. 2001. PMID: 11491530
-
Comparison of chimpanzee and human leukocyte Ig-like receptor genes reveals framework and rapidly evolving genes.J Immunol. 2001 Nov 15;167(10):5786-94. doi: 10.4049/jimmunol.167.10.5786. J Immunol. 2001. PMID: 11698452
-
Expression, purification, and refolding of the myeloid inhibitory receptor leukocyte immunoglobulin-like receptor-5 for structural and ligand identification studies.Protein Expr Purif. 2006 Jun;47(2):490-7. doi: 10.1016/j.pep.2005.11.020. Epub 2005 Dec 20. Protein Expr Purif. 2006. PMID: 16406677
-
The genomic context of natural killer receptor extended gene families.Immunol Rev. 2001 Jun;181:20-38. doi: 10.1034/j.1600-065x.2001.1810102.x. Immunol Rev. 2001. PMID: 11513141 Review.
-
Human cytomegalovirus, MHC class I and inhibitory signalling receptors: more questions than answers.Immunol Rev. 1999 Apr;168:177-85. doi: 10.1111/j.1600-065x.1999.tb01292.x. Immunol Rev. 1999. PMID: 10399074 Review.
Cited by
-
Leukocyte Immunoglobulin-Like Receptors in Regulating the Immune Response in Infectious Diseases: A Window of Opportunity to Pathogen Persistence and a Sound Target in Therapeutics.Front Immunol. 2021 Sep 14;12:717998. doi: 10.3389/fimmu.2021.717998. eCollection 2021. Front Immunol. 2021. PMID: 34594332 Free PMC article. Review.
-
KIR haplotype content at the allele level in 77 Northern Irish families.Immunogenetics. 2007 Feb;59(2):145-58. doi: 10.1007/s00251-006-0181-7. Epub 2007 Jan 3. Immunogenetics. 2007. PMID: 17200871
-
Crystal structure of leukocyte Ig-like receptor LILRB4 (ILT3/LIR-5/CD85k): a myeloid inhibitory receptor involved in immune tolerance.J Biol Chem. 2011 May 20;286(20):18013-25. doi: 10.1074/jbc.M111.221028. Epub 2011 Mar 30. J Biol Chem. 2011. PMID: 21454581 Free PMC article.
-
Perspectives of targeting LILRB1 in innate and adaptive immune checkpoint therapy of cancer.Front Immunol. 2023 Sep 13;14:1240275. doi: 10.3389/fimmu.2023.1240275. eCollection 2023. Front Immunol. 2023. PMID: 37781391 Free PMC article. Review.
-
Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness.Front Immunol. 2019 Sep 11;10:2164. doi: 10.3389/fimmu.2019.02164. eCollection 2019. Front Immunol. 2019. PMID: 31572377 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases